| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
|
|---|---|---|---|---|
| Total Revenue
|
867,793 | 525,553 | 316,296 | 200,767 |
| Cost of Revenue
|
-651,979 | -383,312 | -227,848 | -145,465 |
|
Gross Profit
|
215,814 | 142,241 | 88,448 | 55,302 |
| Selling, General and Administrative Expenses
|
-77,100 | -47,237 | -33,786 | -14,693 |
| Other Income/Expense, Operating
|
-4,344 | -4,162 | 1,618 | -21 |
|
Operating Income/Expenses
|
-81,444 | -51,399 | -32,168 | -14,714 |
|
Total Operating Profit/Loss
|
134,370 | 90,842 | 56,280 | 40,588 |
| Total Net Finance Income/Expense
|
-94,409 | -68,940 | -53,356 | -26,236 |
| Irregular Income/Expenses
|
-11,462 | -23,391 | 137 | -97 |
|
Other Income/Expense, Non-Operating
|
-616 | 433 | 251 | 523 |
|
Non-Operating Income/Expenses, Total
|
-106,487 | -91,898 | -52,968 | -25,810 |
|
Pretax Income
|
27,883 | -1,056 | 3,312 | 14,778 |
|
Provision for Income Tax
|
-4,062 | 1,065 | -320 | -111 |
|
Net Income from Continuing Operations
|
23,821 | 9 | 2,992 | 14,667 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
23,821 | 9 | 2,992 | 14,667 |
|
Non-Controlling/Minority Interests
|
-13,533 | 11,878 | 76,523 | -- |
|
Net Income after Non-Controlling/Minority Interests
|
10,288 | 11,887 | 2,992 | 14,667 |
|
Other Adjustments to Net Income Available to Common Stockholders
|
0 | -16,424 | -- | -- |
|
Net Income Available to Common Stockholders
|
10,288 | -4,537 | 2,992 | 14,667 |
|
Diluted Net Income Available to Common Stockholders
|
10,288 | -4,537 | 2,992 | 14,667 |
|
Common Dividend per Share
|
0.15 | -- | -- | -- |
| Basic EPS
|
0.20 | -0.10 | -0.66 | 0.38 |
| Diluted EPS
|
0.20 | -0.10 | -0.66 | 0.38 |
|
Basic Weighted Average Shares Outstanding
|
47,898.51 | 43,264.85 | 38,509.85 | 38,821.15 |
|
Diluted Weighted Average Shares Outstanding
|
47,898.51 | 43,264.85 | 38,509.85 | 38,821.15 |
|
Reported Normalized Basic EPS
|
-0.66 | -- | -0.66 | -- |
| Income Statement, Supplemental
|
||||
|
EBIT
|
122,292 | 67,884 | 56,668 | 41,014 |
|
EBITDA
|
410,990 | 210,615 | 136,732 | 90,705 |
|
Normalized EBITDA
|
433,268 | 253,987 | 347,101 | 90,443 |
12/31/2023 - 9/17/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade